Mollet IG - Search Results

1

Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.

Clark RA, Huang SJ, Murphy GF, Mollet IG, Hijnen D, Muthukuru M, Schanbacher CF, Edwards V, Miller DM, Kim JE, Lambert J, Kupper TS. Clark RA, et al. Among authors: mollet ig. J Exp Med. 2008 Sep 29;205(10):2221-34. doi: 10.1084/jem.20071190. Epub 2008 Sep 15. J Exp Med. 2008. PMID: 18794336 Free PMC article.

2

Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.

Huang SJ, Hijnen D, Murphy GF, Kupper TS, Calarese AW, Mollet IG, Schanbacher CF, Miller DM, Schmults CD, Clark RA. Huang SJ, et al. Among authors: mollet ig. J Invest Dermatol. 2009 Nov;129(11):2676-85. doi: 10.1038/jid.2009.151. Epub 2009 Jun 11. J Invest Dermatol. 2009. PMID: 19516264 Free PMC article.

3

First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.

van Geel NA, Mollet IG, De Schepper S, Tjin EP, Vermaelen K, Clark RA, Kupper TS, Luiten RM, Lambert J. van Geel NA, et al. Among authors: mollet ig. Pigment Cell Melanoma Res. 2010 Jun;23(3):375-84. doi: 10.1111/j.1755-148X.2010.00703.x. Epub 2010 Apr 1. Pigment Cell Melanoma Res. 2010. PMID: 20370855

4

In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial.

van Geel N, Speeckaert R, Mollet I, De Schepper S, De Wolf J, Tjin EP, Luiten RM, Lambert J, Brochez L. van Geel N, et al. Pigment Cell Melanoma Res. 2012 Jan;25(1):57-65. doi: 10.1111/j.1755-148X.2011.00922.x. Epub 2011 Nov 2. Pigment Cell Melanoma Res. 2012. PMID: 21982055 Clinical Trial.

5

Prognostic value and clinical significance of halo naevi regarding vitiligo.

van Geel N, Vandenhaute S, Speeckaert R, Brochez L, Mollet I, De Cooman L, Lambert J. van Geel N, et al. Br J Dermatol. 2011 Apr;164(4):743-9. doi: 10.1111/j.1365-2133.2010.10154.x. Epub 2011 Mar 16. Br J Dermatol. 2011. PMID: 21114480

6

Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis.

van Geel N, Speeckaert R, Lambert J, Mollet I, De Keyser S, De Schepper S, Brochez L. van Geel N, et al. J Eur Acad Dermatol Venereol. 2012 Jun;26(6):755-61. doi: 10.1111/j.1468-3083.2011.04160.x. Epub 2011 Jun 23. J Eur Acad Dermatol Venereol. 2012. PMID: 21696452

7

Different phenotypes of segmental vitiligo based on a clinical observational study.

van Geel N, De Lille S, Vandenhaute S, Gauthier Y, Mollet I, Brochez L, Lambert J. van Geel N, et al. J Eur Acad Dermatol Venereol. 2011 Jun;25(6):673-8. doi: 10.1111/j.1468-3083.2010.03847.x. Epub 2010 Sep 14. J Eur Acad Dermatol Venereol. 2011. PMID: 20840343

8

New insights in segmental vitiligo: case report and review of theories.

van Geel N, Mollet I, Brochez L, Dutré M, De Schepper S, Verhaeghe E, Lambert J, Speeckaert R. van Geel N, et al. Br J Dermatol. 2012 Feb;166(2):240-6. doi: 10.1111/j.1365-2133.2011.10650.x. Epub 2011 Dec 14. Br J Dermatol. 2012. PMID: 21936857 Review.

9

Alloantisera can detect some of the variants of HLA DRw13 identified by oligotyping.

Gebuhrer L, Lambert J, Labonne MP, Mollet I, Freidel AC, Betuel H. Gebuhrer L, et al. Tissue Antigens. 1992 Jan;39(1):42-7. doi: 10.1111/j.1399-0039.1992.tb02157.x. Tissue Antigens. 1992. PMID: 1542879

10

Origin, clinical presentation, and diagnosis of hypomelanotic skin disorders.

Mollet I, Ongenae K, Naeyaert JM. Mollet I, et al. Dermatol Clin. 2007 Jul;25(3):363-71, ix. doi: 10.1016/j.det.2007.04.013. Dermatol Clin. 2007. PMID: 17662902 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters